StockData
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) stock

DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.43−0.16 (-26.57%)

Close on Nov 17, 2026Market cap $6.56MP/E –Yield –

Dare Bioscience profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Dare Bioscience's profit margin for the twelve months ending Jun 30, 2026 was -804.4%. For fiscal 2025 it was -1300.7%, against -41430.9% the year before. The highest annual figure on record is -87.8% in fiscal 2016.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-1300.7%+40130.2
FY2024Dec 31, 2024-41430.9%−40356.7
FY2023Dec 31, 2023-1074.2%−764.7
FY2022Dec 31, 2022-309.5%−221.7
FY2016Dec 31, 2016-87.8%+29089.7
FY2014Dec 31, 2014-29177.5%+256539.2
FY2013Dec 31, 2013-285716.7%−282180.5
FY2012Dec 31, 2012-3536.2%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-1590.4%+15628.7
Q1 FY2026Mar 31, 2026-1967.7%+9311.7
Q4 FY2025Dec 31, 2025-140.8%−57680.1
Q3 FY2025Sep 30, 2025-157505.1%−84882.5
Q1 FY2025Mar 31, 2025-17219.1%−16939.4
Q3 FY2024Sep 30, 2024-11279.4%−10449.5
Q2 FY2024Jun 30, 202457539.2%+57535.1
Q1 FY2024Mar 31, 2024-72622.6%−72545.0
Q4 FY2023Dec 31, 2023-279.8%−259.3
Q3 FY2023Sep 30, 2023-829.9%−184.3
Q2 FY2022Jun 30, 20224.1%–
Q2 FY2017Jun 30, 2017-77.6%–
Q1 FY2017Mar 31, 2017-20.5%–
Q4 FY2016Dec 31, 2016-645.6%–

More Dare Bioscience figures

See a number that looks wrong?